• Most Popular
  • Most Shared

UPDATE 1-Thoratec heart device shows promise

Thu Dec 4, 2008 5:42pm EST

Stocks

   

(Adds details)

Stocks  |  Regulatory News  |  Global Markets

Dec 4 (Reuters) - Cardiac device maker Thoratec Corp (THOR.O) said an interim analysis of a late-stage study showed its HeartMate II device to be statistically superior to an existing heart pump, sending its shares up 14 percent after the bell.

Thoratec said the study compared the company's device as a destination therapy -- treatment for patients who do not qualify for a transplant -- to its currently marketed heart pump called HeartMate XVE.

The HeartMate II cardiac device is intended for advanced-stage heart failure patients, and the company plans to file for a pre-market approval for its use as a destination therapy with the U.S. Food and Drug Administration in the first half of 2009.

Thoratec's shares, which closed at $24.75 Thursday on Nasdaq, were trading up about $3 at $27.54 after the bell. (Reporting by Vidya L Nathan in Bangalore; Editing by Anil D'Silva)

Stocks
Regulatory News
Global Markets


More from Reuters

Photo

New security restrictions could hurt airlines

NEW YORK (Reuters) - Tighter security measures at U.S. airports following an attempt to blow up a Detroit-bound jet could dampen enthusiasm for air travel, hurting the airline industry just as it seemed poised to recover from a period of bruising losses, some industry experts say.

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets